文献速递疼痛医学神经外科与老年麻醉

慢性下背痛患者加巴喷丁处方与痴呆风险关联研究

Risk of dementia following gabapentin prescription in chronic low back pain patients.
PubMed 文献 · Reg Anesth Pain Med · 2026-10-05

本研究基于TriNetX数据库2004至2024年记录,采用回顾性队列设计,纳入慢性下背痛成人并经倾向评分匹配分析26416例。结果显示,加巴喷丁处方≥6次者痴呆(RR 1.29;95%CI 1.18-1.40)与轻度认知障碍(RR 1.85;95%CI 1.63-2.10)发生率升高,非老年成人(18-64岁)风险更高。

要点

  • 加巴喷丁处方≥6次与痴呆及轻度认知障碍风险升高相关
  • 非老年成人(18-64岁)处方加巴喷丁者痴呆风险为未处方者2倍以上
  • 处方频率越高,痴呆与轻度认知障碍发生风险进一步增加

核心结论

  • 慢性下背痛成人中,加巴喷丁处方与痴呆及认知障碍风险升高相关,非老年成人尤为明显。

研究设计与样本

  • 回顾性队列研究,使用TriNetX国家数据库2004至2024年去标识化患者记录。
  • 纳入慢性下背痛成人,排除既往加巴喷丁使用、痴呆、癫痫、卒中或癌症者。
  • 采用倾向评分匹配控制人口学、合并症及镇痛药物,按年龄和加巴喷丁处方频率分层。
  • 倾向评分匹配后分析26416例成人。

主要发现

  • 加巴喷丁处方≥6次者痴呆发生率升高(RR 1.29;95%CI 1.18-1.40)。
  • 加巴喷丁处方≥6次者轻度认知障碍发生率升高(RR 1.85;95%CI 1.63-2.10)。
  • 非老年成人(18-64岁)处方加巴喷丁者痴呆风险为未处方者2倍以上(RR 2.10;95%CI 1.75-2.51)。
  • 非老年成人(18-64岁)处方加巴喷丁者轻度认知障碍风险为未处方者2倍以上(RR 2.50;95%CI 2.04-3.05)。
  • 处方≥12次者较处方3-11次者痴呆(RR 1.40;95%CI 1.25-1.57)与轻度认知障碍(RR 1.65;95%CI 1.42-1.91)发生率更高。

关键数值与推荐

  • 加巴喷丁处方≥6次与痴呆风险升高相关(RR 1.29;95%CI 1.18-1.40)。
  • 加巴喷丁处方≥6次与轻度认知障碍风险升高相关(RR 1.85;95%CI 1.63-2.10)。
  • 非老年成人(18-64岁)加巴喷丁处方者痴呆风险RR 2.10(95%CI 1.75-2.51)。
  • 非老年成人(18-64岁)加巴喷丁处方者轻度认知障碍风险RR 2.50(95%CI 2.04-3.05)。
  • 处方≥12次者较3-11次者痴呆风险RR 1.40(95%CI 1.25-1.57),轻度认知障碍风险RR 1.65(95%CI 1.42-1.91)。

临床怎么用

  • 对处方加巴喷丁的慢性下背痛患者应监测认知结局。
  • 非老年成人使用加巴喷丁时需关注痴呆与认知障碍风险。
  • 处方频率较高者可能需更密切的认知功能随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Gabapentin is widely used to treat chronic pain, but its association with cognitive decline and dementia remains unclear. This study examined whether gabapentin prescription is associated with dementia in adults with chronic low back pain. METHODS: We conducted a retrospective cohort study using the TriNetX national database of de-identified patient records from 2004 to 2024. Adults diagnosed with chronic low back pain were included; those with prior gabapentin use, dementia, epilepsy, stroke, or cancer were excluded. Propensity score matching controlled for demographics, comorbidities, and pain medications. Patients were stratified by age and gabapentin prescription frequency. Primary outcomes were dementia and mild cognitive impairment. RESULTS: 26,416 adults we analyzed following propensity-score matching. Patients with six or more gabapentin prescriptions had an increased incidence of dementia (RR: 1.29; 95% CI: 1.18-1.40) and mild cognitive impairment (RR: 1.85; 95% CI: 1.63-2.10). When stratified by age, non-elderly adults (18-64) prescribed gabapentin had over twice the risk of dementia (RR: 2.10; 95% CI: 1.75-2.51) and mild cognitive impairment (RR: 2.50; 95% CI: 2.04-3.05) compared to those not prescribed gabapentin. Risk increased further with prescription frequency: patients with 12 or more prescriptions had a higher incidence of dementia (RR: 1.40; 95% CI: 1.25-1.57) and mild cognitive impairment (RR: 1.65; 95% CI: 1.42-1.91) than those prescribed gabapentin 3-11 times. CONCLUSIONS: Gabapentin prescription in adults with chronic low back pain is associated with increased risk of dementia and cognitive impairment, particularly in non-elderly adults. Physicians should monitor cognitive outcomes in patients prescribed gabapentin.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Eghrari NB, Yazji IH, Yavari B, et al. Risk of dementia following gabapentin prescription in chronic low back pain patients. Reg Anesth Pain Med. 2026. PMID: 40639955. doi:10.1136/rapm-2025-106577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。